TheraRadar
Data updated: May 26, 2026

AMPICILLIN SODIUM

Infectious Disease Approved 1971-03-03

AMPICILLIN SODIUM is indicated for the treatment of Respiratory Tract Infection; Bacterial Meningitis; Septicemia; Endocarditis; Urinary Tract Infection; Gastrointestinal Infection; Typhoid Fever; Dysentery.

Source: FDA Label • WATSON LABS INC
17
Indications
--
Phase 3 Trials
55
Years on Market

AMPICILLIN SODIUM Approval History

1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
463 FDA actions from 1971 to 2024
May 2024 SUPPL
Label · Labeling
Apr 2024 SUPPL
Label · Labeling
Mar 2024 SUPPL
Label · Labeling

What AMPICILLIN SODIUM Treats

8 indications

AMPICILLIN SODIUM is approved for 8 conditions since its original approval in 1971. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Respiratory Tract Infection
  • Bacterial Meningitis
  • Septicemia
  • Endocarditis
  • Urinary Tract Infection
  • Gastrointestinal Infection
  • Typhoid Fever
  • Dysentery
Source: FDA Label

AMPICILLIN SODIUM Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to AMPICILLIN SODIUM

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ANCOBON
FLUCYTOSINE
3 shared
BAUSCH
Shared indications:
FLUCYTOSINE
FLUCYTOSINE
3 shared
LAURUS
Shared indications:
ARIKAYCE KIT
AMIKACIN SULFATE
2 shared
INSMED INC
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

AMPICILLIN SODIUM FDA Label Details

Indications & Usage

AMPICILLIN SODIUM is indicated for the treatment of Respiratory Tract Infection; Bacterial Meningitis; Septicemia; Endocarditis; Urinary Tract Infection; Gastrointestinal Infection; Typhoid Fever; Dysentery.

Looking for the branded version?

AMPICILLIN AND SULBACTAM

Full clinical data, patents, trials, and competitive landscape for ampicillin sodium.

See AMPICILLIN AND SULBACTAM

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.